To report a case of successful treatment of refractory hot flashes with gabapentin in a patient with pros

Luteinizing hormone-releasing hormone analogue, 3.6 mg goserelin acetate and flutamide, 375 mg per day we

Although androgen supplementation is clearly indicated in most hypogonadal males, it is also gaining popu

The conventional treatment for localized prostate cancer can be associated with significant morbidity and

A 65-year-old man undergoes a routine checkup before retiring. His wife has urged him to have his prostat

A 67-year-old man with hormone-refractory (stage D2) prostate cancer was admitted to the hospital because

In the irradiation of prostate cancer internal organ movement leads to uncertainties in the daily localiz

Androgen blockage, with either orchiectomy or luteinizing hormone releasing hormone (LHRH) analogs combin

We report a case of primary adenocarcinoma of the prostate cancer producing carcinoembryonic antigen (CEA

Dehydroepiandrosterone (DHEA) is being evaluated in the basic science laboratories as a potential treatme